Physician profile
Jay Kothari
NPI 1700142924
$478.48
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.52 · 2020: $74.77 · 2021: $64.56 · 2022: $136 · 2023: $16.85 · 2024: $34.78 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $204.20 | 2020-2025 | Sapien 3 Ultra Resilia, Hemosphere |
| Chiesi USA, INC. | $86.62 | 2019-2022 | |
| Abiomed | $34.48 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $31.45 | 2022-2025 | Exparel |
| Merck Sharp & Dohme LLC | $29.31 | 2022-2023 | Bridion |
| Csl Behring | $25.21 | 2022 | |
| Ambu INC. | $22.12 | 2021 | |
| La Jolla Pharmaceutical Company | $17.26 | 2025 | Giapreza |
| Acelrx Pharmaceuticals, INC. | $14.94 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Kothari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.